Research graph
References from Expanding the clinicopathological spectrum of BAP1 mutated ccRCC: a study of 84 cases in multi-center cohort. Local targets link to admitted publications; unresolved targets remain external evidence.
BAP1 and cancer
10.1038/nrc3459 · 2013 · External reference
BAP1: not just a BRCA1-associated protein
10.1016/j.ctrv.2020.102091 · 2020 · External reference
Biological mechanisms and clinical significance of BAP1 mutations in human cancer
10.1158/2159-8290.cd-19-1220 · 2020 · External reference
Molecular genetics of clear-cell renal cell carcinoma
10.1200/jco.2012.45.2003 · 2014 · External reference
BAP1 loss defines a new class of renal cell carcinoma
10.1038/ng.2323 · 2012 · External reference
BAP1-Mutated clear cell renal cell carcinoma
10.1093/ajcp/aqaa176 · 2021 · External reference
Biomarker analyses from the phase III randomized CLEAR trial: lenvatinib plus pembrolizumab versus sunitinib in advanced renal cell carcinoma
10.1016/j.annonc.2024.12.003 · 2025 · External reference
An overview of BAP1 biological functions and current therapeutics
10.1016/j.bbcan.2025.189267 · 2025 · External reference
Clinical benefit of Niraparib to TKI/mTORi-Resistance metastatic ccRCC with BAP1-Frame shift mutation: case report and literature review
10.3389/fonc.2022.927250 · 2022 · External reference
Integration of recurrent somatic mutations with clinical outcomes: a pooled analysis of 1049 patients with clear cell renal cell carcinoma
10.1016/j.euf.2016.06.015 · 2017 · External reference
Clear cell renal cell carcinoma subtypes identified by BAP1 and PBRM1 expression
10.1016/j.juro.2015.07.113 · 2016 · External reference
Histopathologic and proteogenomic heterogeneity reveals features of clear cell renal cell carcinoma aggressiveness
10.1016/j.ccell.2022.12.001 · 2023 · External reference
Prognostic value of BAP1 protein expression in uveal melanoma
10.1097/pas.0000000000002176 · 2024 · External reference
